Komori
Nippon Soda (4041) · InitiativeAdvanced

Enhancing the Fairness and Objectivity of Executive Compensation through the Compensation Advisory Committee

First written in FY2017. 3 of 8 entries say "Restated". Latest entry: FY2026.

8entries
10years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017 – FY2018AdvancedFY2021 – FY20222017: 120172018: 120182019: 120192020: 120202021: 120212022: 120222023: 020232024: 020242025: 020252026: 22026
Same theme, other companies
Operation of the Nomination and Compensation Committee Centered on Independent Outside DirectorsA theme 196 companies write about · 0 as a headwind · 196 as a tailwind

The whole theme swung hardest in 2025: 9 of 89 companies on the "Worse" side.

66 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「To improve the fairness and objectivity of executive appointments, including succession planning, and executive compensation, the company established an independent and effective Nomination and Compensation Advisory Committee chaired by an outside director and comprising 3 outside directors and the president. The committee provides advice and reports to the Board of Directors regarding executive appointments and compensation.」

    The structure of the Nomination and Compensation Advisory Committee was disclosed: it is chaired by an outside director and comprises 3 outside directors and the president. It met 7 times during the current fiscal year.
  2. 2026-05-29RestatedGeneral Meetings of Shareholders

    「当該取締役会の決議に際しては、あらかじめ決議する内容について指名・報酬諮問委員会へ諮問し、答申を受けております。」

    指名・報酬諮問委員会への諮問・答申を経た報酬決定手続を継続している。
  3. FY2022AdvancedAnnual report

    「At meetings held on 22 April 2022 and 29 June 2022, the Board of Directors partially changed the policy and adopted a new resolution.」

    Following consultation with and a report from the Nomination and Compensation Advisory Committee, the performance-linked compensation metrics were changed to changes in consolidated net income, changes in consolidated ROE, and changes in the standalone operating profit margin. The compensation mix was also revised to approximately 40% base compensation, 40% performance-linked compensation, 5% evaluation-based compensation, and 15% share-based compensation.
  4. FY2021AdvancedAnnual report

    「At a meeting held on 26 February 2021, the Board of Directors resolved the policy for determining the details of individual compensation for directors (excluding outside directors, part-time directors and directors who are Audit and Supervisory Committee members; hereinafter, “directors”).」

    In addition to compensation decisions through the Nomination and Compensation Advisory Committee, the Board of Directors resolved a policy for determining individual compensation on 26 February 2021. The policy also specified a framework using changes in consolidated ordinary profit and the change in the standalone operating profit margin for performance-linked compensation, and ROE and changes in consolidated operating profit for share-based compensation.
  5. FY2020RestatedAnnual report

    「To improve the fairness and objectivity of executive appointments and compensation, the company established a Nomination and Compensation Advisory Committee comprising 2 outside directors and the president. The committee provides advice and recommendations to the Board of Directors regarding executive appointments and compensation.」

    The expanded role of the committee, from the Compensation Advisory Committee to the Nomination and Compensation Advisory Committee, and its function of providing advice and recommendations to the Board of Directors continue.
  6. FY2019ReframedAnnual report

    「Within the limit of total compensation approved by the General Meeting of Shareholders, the Board of Directors consults the Nomination and Compensation Advisory Committee on director compensation, deliberates on the matter after receiving its advice, recommendations and reports, and makes the decision.」

    The description was expanded from the former Compensation Advisory Committee to the “Nomination and Compensation Advisory Committee,” with the compensation decision-making process through advice and reports to the Board of Directors explicitly stated.
  7. FY2018RestatedAnnual report

    「In January 2017, the company established a Compensation Advisory Committee comprising the president and 2 outside directors to improve the fairness and objectivity of executive compensation. The committee provides advice and recommendations to the president regarding executive compensation.」

    The role of the Compensation Advisory Committee, established in January 2017 and comprising the president and 2 outside directors, was reiterated.
  8. FY2017First statedAnnual report

    「In January 2017, the company established a Compensation Advisory Committee comprising the president and 2 outside directors to improve the fairness and objectivity of executive compensation. The committee provides advice and recommendations to the president regarding executive compensation.」

    In January 2017, the company established a Compensation Advisory Committee comprising the president and 2 outside directors.
Moved together

"Development and Commercialization of a New Pesticide Pipeline" moved the same way as this thread, in the same document, in 3 of its 8 moves.

333332★123456
  1. ★This thread
  2. 1Development and Commercialization of a New Pesticide Pipeline3×
  3. 2Stable dividends targeting a total payout ratio of 30%3×
  4. 3Expected earnings decline due to weak market conditions for Novus's feed-additive methionine3×
  5. 4Annual Review of the Rationale for Strategic Shareholdings3×
  6. 5Long-Term Management Vision “Shine through Chemistry. 2030” and Medium-Term Management Plan “Shine through Chemistry. Stage I”3×
  7. 6R&D Investment to Create High-Value-Added Products and New Businesses2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Nippon Soda yet. It last moved in the General Meetings of Shareholders of 2026-05-29: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.